Please wait ...

Andrew Penn, RN, MS, NP, CNS, APRN-BC

Andrew Penn MS, PMHNP, UC San Francisco trained psychiatric nurse practitioner. Associate clinical professor in the UCSF School of Nursing, practicing at the San Francisco VA. He has worked as study therapist on a MDMA-assisted therapy protocol for PTSD.


Speaker Disclosures:
Financial: Andrew Penn is an associate clinical professor at UCSF School of Nursing. He has an employment relationship with the San Francisco Veterans Administration Hospital. He is a steering committee member and nurse planner for North American Center for Continuing Medical Education (NACCME). Mr. Penn is a study therapist for Multidisciplinary Association for Psychedelics Studies, UCSF Langley Porter Institute, BAND Lab. He will address off-label uses.
Non-financial: Andrew Penn is the co-founder of the Organization of Psychedelic and Entheogenic Nurses. He is the founder of UCSF School of Nursing Psychedelic Therapy Journal Club. Mr. Penn is a member of the American Psychiatric Nurses Association.


The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and other Mental Distress

Michael Mithoefer, MD |  Rick Doblin, Ph.D. |  Phil Wolfson, MD |  Sue Carter, PhD |  Robin Carhart-Harris, PhD |  Andrew Penn, RN, MS, NP, CNS, APRN-BC |  Richard C. Schwartz, Ph.D. |  Anne Wagner, PhD, C Psych |  ....
3 Hours 59 Minutes
May 18, 2021
Product Code:
Media Type:
Digital Seminar
$119.95 - Trauma Sale Standard - $199.95

Showing 1 to 1 of 1 entries